UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 480

Sortiert nach

Insights into adenovirus host cell interactions from structural studies

Virology (New York, N.Y.), 2009-02, Vol.384 (2), p.380-388

2009

Volltextzugriff (PDF)

PP 5.4 – 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents

Journal of Virus Eradication, 2022-12, Vol.8, p.100243, Article 100243

2022

Volltextzugriff (PDF)

Production institutionnelle de l’enfance: Déclinaisons locales et pratiques d’acteurs

2016

Volltextzugriff (PDF)

Optimisation of Smac mimetics as HIV-1 latency reversing agents

Journal of Virus Eradication, 2019-12, Vol.5, p.37

2019

Volltextzugriff (PDF)

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up

British journal of cancer, 1994-03, Vol.69 (3), p.566-571

1994

Volltextzugriff (PDF)

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

British Journal of Cancer, 1999-04, Vol.79 (11-12), p.1746-1751

1999

Volltextzugriff (PDF)

Urokinase (uPA) and PAI-1 Predict Survival in Advanced Ovarian Cancer Patients (FIGO III) after Radical Surgery and Platinum-Based Chemotherapy

Gynecologic oncology, 1994-12, Vol.55 (3), p.401-409

1994

Volltextzugriff (PDF)

Acteurs et action: Perspectives en didactiques de l’histoire et de la géographie

2016

Volltextzugriff (PDF)

Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2

Cancer research (Chicago, Ill.), 1995-09, Vol.55 (18), p.3958-3963

1995

Volltextzugriff (PDF)

Membrane Cofactor Protein Is a Receptor for Adenoviruses Associated with Epidemic Keratoconjunctivitis

Journal of Virology, 2004-04, Vol.78 (8), p.3897-3905

2004

Volltextzugriff (PDF)

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

British journal of cancer, 1997, Vol.75 (10), p.1525-1533

1997

Volltextzugriff (PDF)

Flexibility of the Adenovirus Fiber Is Required for Efficient Receptor Interaction

Journal of Virology, 2003-07, Vol.77 (13), p.7225-7235

2003

Volltextzugriff (PDF)

Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses

Virology (New York, N.Y.), 2008-06, Vol.375 (2), p.573-579

2008

Volltextzugriff (PDF)

The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV

International journal of gynecological cancer, 1998-01, Vol.8 (1), p.56-63

1998

Volltextzugriff (PDF)

Ojo rojo grave: glaucoma agudo

Atención primaria, 2019, Vol.51 (1), p.54-55

2019

Volltextzugriff (PDF)

Disease-adapted relapse therapy for ovarian cancer: results of a prospective study

International journal of oncology, 1998-07, Vol.13 (1), p.57

1998

Volltextzugriff (PDF)

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

Breast cancer research and treatment, 1993-10, Vol.24 (3), p.195-208

1993

Volltextzugriff (PDF)

Tumor-associated urokinase-type plasminogen activator: biological and clinical significance

Biological chemistry Hoppe-Seyler, 1992-07, Vol.373 (7), p.611

1992

Volltextzugriff (PDF)

Prognostic value of the cysteine proteases cathespins B and cathepsin L in human breast cancer

Clinical cancer research, 1995-07, Vol.1 (7), p.741-746

1995

Volltextzugriff (PDF)

Entwicklungen in der Therapie des fortgeschrittenen Ovarialkarzinoms FIGO III

Geburtshilfe und Frauenheilkunde, 1993-05, Vol.53 (5), p.293-302

1993

Volltextzugriff (PDF)

Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1

Cancer research (Chicago, Ill.), 1994-05, Vol.54 (10), p.2527-2530

1994

Volltextzugriff (PDF)

Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer

Clinical cancer research, 1995-07, Vol.1 (7), p.741-746

1995

Volltextzugriff (PDF)

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

Cancer, 1992-10, Vol.70 (8), p.2129-2136

1992

Volltextzugriff (PDF)

Flexibility of the Adenovirus Fiber Is Required for Efficient Receptor Interaction

Journal of virology, 2004-02, Vol.78 (4), p.2167-2167

2004

Volltextzugriff (PDF)

1 – 25 von 480

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(363)
Mit Volltextzugriff
(398)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Insights into adenovirus host cell interactions from structural studies

PP 5.4 – 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents

Production institutionnelle de l’enfance: Déclinaisons locales et pratiques d’acteurs

Optimisation of Smac mimetics as HIV-1 latency reversing agents

Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

Urokinase (uPA) and PAI-1 Predict Survival in Advanced Ovarian Cancer Patients (FIGO III) after Radical Surgery and Platinum-Based Chemotherapy

Acteurs et action: Perspectives en didactiques de l’histoire et de la géographie

Production institutionnelle de l’enfance

Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2

Membrane Cofactor Protein Is a Receptor for Adenoviruses Associated with Epidemic Keratoconjunctivitis

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer

Flexibility of the Adenovirus Fiber Is Required for Efficient Receptor Interaction

Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses

The influence of upper abdominal surgery on perioperative morbidity and mortality in patients with advanced ovarian cancer FIGO III and FIGO IV

Ojo rojo grave: glaucoma agudo

Disease-adapted relapse therapy for ovarian cancer: results of a prospective study

Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer

Tumor-associated urokinase-type plasminogen activator: biological and clinical significance

Prognostic value of the cysteine proteases cathespins B and cathepsin L in human breast cancer

Entwicklungen in der Therapie des fortgeschrittenen Ovarialkarzinoms FIGO III

Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1

Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer

Radical surgical procedure improves survival time in patients with recurrent ovarian cancer

Flexibility of the Adenovirus Fiber Is Required for Efficient Receptor Interaction

Suchergebnisse filtern